Prosecution Insights
Last updated: October 25, 2026

BIORCHESTRA CO., LTD.

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

BIORCHESTRA CO., LTD. manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units.

VANHORN, ABIGAIL LOUISE is the busiest examiner, holding 1 pending office action. With 2 distinct examiners each managing an action, the company's current prosecution workload is split evenly between the two identified art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
§112 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VANHORN, ABIGAIL LOUISE 1 46.8% +22.7%
KONOPKA, CATHERINE ANNE 1 57.5% +66.2%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18259618 MICELLAR NANOPARTICLES AND USES THEREOF VANHORN, ABIGAIL LOUISE —
18259007 USE OF MIRNA-485 INHIBITORS FOR INDUCING HAIR GROWTH KONOPKA, CATHERINE ANNE —

Top Art Units

Art UnitApps
1636 1
1635 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18259618 MICELLAR NANOPARTICLES AND USES THEREOF VANHORN, ABIGAIL LOUISE 1636 §103Other Final Rejection — Pending Jun 28, 2023
18259007 USE OF MIRNA-485 INHIBITORS FOR INDUCING HAIR GROWTH KONOPKA, CATHERINE ANNE 1635 §112 Non-Final OA — Pending Jun 22, 2023

Managing BIORCHESTRA CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does BIORCHESTRA CO., LTD. have?

BIORCHESTRA CO., LTD. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most BIORCHESTRA CO., LTD. applications?

Abigail Louise Vanhorn has the most, with 1 of BIORCHESTRA CO., LTD.'s pending office actions.

What technology area are BIORCHESTRA CO., LTD.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month